The synergistic interaction was found between RAPA and HF in the suppression of T cell proliferation (Fig 1, Table 1), suggesting that HF is a potential adjuvant to enhance the therapeutic effects of RAPA-based immunosuppressive protocol on T cell-mediated graft rejection. This evidence concerns the gene TRERF1 and hydrops fetalis.